The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Identification of erythroferrone as an erythroid regulator of iron metabolism
Open accessAbstract
Recovery from blood loss requires a greatly enhanced supply of iron to support expanded erythropoiesis. After hemorrhage, suppression of the iron-regulatory hormone hepcidin allows increased iron absorption and mobilization from stores. We identified a new hormone, erythroferrone (ERFE), that mediates hepcidin suppression during stress erythropoiesis. ERFE is produced by erythroblasts in response to erythropoietin. ERFE-deficient mice fail to suppress hepcidin rapidly after hemorrhage and exhibit a delay in recovery from blood loss. ERFE expression is greatly increased in Hbb(th3/+) mice with thalassemia intermedia, where it contributes to the suppression of hepcidin and the systemic iron overload characteristic of this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In iron-loading anemias, such as β-thalassemia, enhanced albeit ineffective ery-thropoiesis releases erythroferrone, which sequesters BMP receptor ligands, thereby inhibiting hepcidin.”
From Iron metabolism and iron disorders revisited in the hepcidin era (2020) · cites this paper as [52]
In the citing paper
“Erythroferrone (ERFE) is released by erythroid precursors stimulated by erythropoietin to suppress hepcidin expression and favor iron acquisition for hemoglobin synthesis.52”
From Iron metabolism and iron disorders revisited in the hepcidin era (2020) · cites this paper as [52]
In the citing paper
“Another set of regulatory factors conveys the iron requirements for erythropoiesis and includes the recently identified hormone erythroferrone12, which is produced by erythroblasts in response to erythropoietic stimulation by endogenous or synthetic erythropoietin. Erythroferrone suppresses hepcidin synthesis, making more iron available for enhanced erythropoiesis.”
From Iron homeostasis in host defence and inflammation (2015) · cites this paper as [12]
In the citing paper
“Despite high concentrations of iron and deposition of iron in the liver and other vital organs, the blood level of hepcidin in untransfused patients with β-thalassaemia is very low38–40, owing to suppression by mediators originating from the expanded erythroblast population in the bone marrow12,41.”
From Iron homeostasis in host defence and inflammation (2015) · cites this paper as [12]
In the citing paper
“Erythroferrone (ERFE) is produced by erythropoietin (EPO)-stimulation of erythroid progenitors and blocks hepcidin synthesis in the hepatocytes (Kautz et al., 2014).”
From The Role of Iron Regulation in Immunometabolism and Immune-Related Disease (2019) · cites this paper as Kautz et al., 2014
In the citing paper
“and repressed in response to: (i) hypoferremia, that is, lower than normal levels of circulating Fe, (ii) anemia, (iii) tissue hypoxia, and (iv) hormones, for example, growth and differentiation factors 15, erythroferrone, platelet-derived growth factor-BB (PDGF-BB) and testosterone [62][63][64][65].”
From The Iron age of host–microbe interactions (2015) · cites this paper as [62]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pfaffl, M. W. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.9.e36 · Cited by 7,377
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,836
Ganz, T., & Nemeth, E. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.01.014 · Cited by 1,282
Self-citationNicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A., & Vaulont, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215686 · Cited by 1,214
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
Tanno, T., Bhanu, N. V., Oneal, P. A., Goh, S.-H., Staker, P., Lee, Y. T., Moroney, J. W., Reed, C. H., Luban, N. L., Wang, R.-H., et al. (2007) · Nature Medicine · doi:10.1038/nm1629 · Cited by 854
Self-citationBMP6 is a key endogenous regulator of hepcidin expression and iron metabolism
Andriopoulos Jr, B., Corradini, E., Xia, Y., Faasse, S. A., Chen, S., Grgurevic, L., Knutson, M. D., Pietrangelo, A., Vukicevic, S., Lin, H. Y., et al. (2009) · Nature Genetics · doi:10.1038/ng.335 · Cited by 769
Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)
Peyssonnaux, C., Zinkernagel, A. S., Schuepbach, R. A., Rankin, E., Vaulont, S., Haase, V. H., Nizet, V., & Johnson, R. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31370 · Cited by 639
Lack of the bone morphogenetic protein BMP6 induces massive iron overload
Meynard, D., Kautz, L., Darnaud, V., Canonne-Hergaux, F., Coppin, H., & Roth, M.-P. (2009) · Nature Genetics · doi:10.1038/ng.320 · Cited by 587
Self-citationSuppression of hepcidin during anemia requires erythropoietic activity
Pak, M., Lopez, M. A., Gabayan, V., Ganz, T., & Rivera, S. (2006) · Blood · doi:10.1182/blood-2006-06-028787 · Cited by 472
Self-citationRegulators of iron balance in humans [see comments]
Finch, C. (1994) · Blood · doi:10.1182/blood.v84.6.1697.1697 · Cited by 455
Flagged first, then by citations
1 of the 44 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 1,000
Suzuki, N., & Yamamoto, M. P. (2015) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-015-1740-2 · Cited by 63
Therapeutic Advances in Regulating the Hepcidin/Ferroportin Axis
Hawula, Z. J., Wallace, D. F., Subramaniam, V. N., & Rishi, G. (2019) · Pharmaceuticals · doi:10.3390/ph12040170 · Cited by 62
Regulation of Iron Homeostasis and Related Diseases
Li, Y., Huang, X., Wang, J., Huang, R., & Wan, D. (2020) · Mediators of Inflammation · doi:10.1155/2020/6062094 · Cited by 66
Revisiting hemochromatosis: genetic vs. phenotypic manifestations
Anderson, G. J., & Bardou‐Jacquet, E. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-5512 · Cited by 68
New Insights Into Pathophysiology of β-Thalassemia
Sánchez‐Villalobos, M., Blanquer, M., Moraleda, J. M., Salido, E. J., & Pérez‐Oliva, A. B. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.880752 · Cited by 73
The erythroblastic island as an emerging paradigm in the anemia of inflammation
Hom, J., Dulmovits, B. M., Mohandas, N., & Blanc, L. (2015) · Immunologic Research · doi:10.1007/s12026-015-8697-2 · Cited by 66
Therapeutic targeting of the HIF oxygen-sensing pathway: Lessons learned from clinical studies
Haase, V. H. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.05.004 · Cited by 65
Colucci, S., Pagani, A., Pettinato, M., Artuso, I., Nai, A., Camaschella, C., & Silvestri, L. (2017) · Blood · doi:10.1182/blood-2017-04-780692 · Cited by 62
Kawabata, H. (2017) · International Journal of Hematology · doi:10.1007/s12185-017-2365-3 · Cited by 64
Hypoxia-inducible factor stabilizers for treating anemia of chronic kidney disease
Hasegawa, S., Tanaka, T., & Nangaku, M. (2018) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000431 · Cited by 63
Macrophage ferroportin is essential for stromal cell proliferation in wound healing
Recalcati, S., Gammella, E., Buratti, P., Doni, A., Anselmo, A., Locati, M., & Cairo, G. (2018) · Haematologica · doi:10.3324/haematol.2018.197517 · Cited by 68
The changing landscape of iron deficiency
Camaschella, C., & Girelli, D. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100861 · Cited by 70
2021 update on clinical trials in β‐thalassemia
Musallam, K. M., Bou‐Fakhredin, R., Cappellini, M. D., & Taher, A. T. (2021) · American Journal of Hematology · doi:10.1002/ajh.26316 · Cited by 66
The Multiple Facets of Iron Recycling
Slusarczyk, P., & Mleczko‐Sanecka, K. (2021) · Genes · doi:10.3390/genes12091364 · Cited by 64
Ozaki, Y., Ohashi, K., Otaka, N., Kawanishi, H., Takikawa, T., Fang, L., Takahara, K., Tatsumi, M., Ishihama, S., Takefuji, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40435-2 · Cited by 63
Porter, J. B., Cappellini, M. D., Kattamis, A., Viprakasit, V., Musallam, K. M., Zhu, Z., & Taher, A. T. (2016) · British Journal of Haematology · doi:10.1111/bjh.14373 · Cited by 60
Erythropoietin's inhibiting impact on hepcidin expression occurs indirectly
Gammella, E., Diaz, V., Recalcati, S., Buratti, P., Samaja, M., Dey, S., Noguchi, C. T., Gassmann, M., & Cairo, G. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00410.2014 · Cited by 59
Donker, A. E., van der Staaij, H., & Swinkels, D. W. (2021) · Blood Reviews · doi:10.1016/j.blre.2021.100866 · Cited by 76
Cellular sensing and transport of metal ions: implications in micronutrient homeostasis
Bird, A. J. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.08.002 · Cited by 60
Modulation of hepcidin to treat iron deregulation: potential clinical applications
Blanchette, N. L., Manz, D. H., Torti, F. M., & Torti, S. V. (2015) · Expert Review of Hematology · doi:10.1586/17474086.2016.1124757 · Cited by 59
Lobe specificity of iron binding to transferrin modulates murine erythropoiesis and iron homeostasis
Parrow, N. L., Li, Y., Feola, M., Guerra, A., Casu, C., Prasad, P., Mammen, L., Ali, F., Vaicikauskas, E., Rivella, S., et al. (2019) · Blood · doi:10.1182/blood.2018893099 · Cited by 59
Self-citation2017 Clinical trials update in new treatments of β‐thalassemia
Makis, A. C., Hatzimichael, E. C., Papassotiriou, I., & Voskaridou, E. (2016) · American Journal of Hematology · doi:10.1002/ajh.24530 · Cited by 60
The Role of Intravenous Iron in the Treatment of Anemia Associated with Cancer and Chemotherapy
Rodgers, G. M., & Gilreath, J. A. (2019) · Acta Haematologica · doi:10.1159/000496967 · Cited by 58
Stabilizing HIF to Ameliorate Anemia
Voit, R. A., & Sankaran, V. G. (2020) · Cell · doi:10.1016/j.cell.2019.12.010 · Cited by 58
Yanatori, I., Richardson, D. R., Toyokuni, S., & Kishi, F. (2020) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2020.129685 · Cited by 61
Ha, J., Doğuer, Ç., Wang, X., Flores, S. R., & Collins, J. F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161033 · Cited by 57
Anaemia, iron homeostasis and pulmonary hypertension: a review
Sonnweber, T., Pizzini, A., Tancevski, I., Löffler‐Ragg, J., & Weiß, G. (2020) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02288-1 · Cited by 59
Cell‐type‐specific insights into iron regulatory processes
Mleczko‐Sanecka, K., & Silvestri, L. (2020) · American Journal of Hematology · doi:10.1002/ajh.26001 · Cited by 64
Puliyel, M. M., Mainous, A. G., Berdoukas, V. A., & Coates, T. D. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.10.861 · Cited by 54
Pasricha, S., & Drakesmith, H. (2016) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.11.003 · Cited by 57
Current Review of Iron Overload and Related Complications in Hematopoietic Stem Cell Transplantation
Atilla, E., Toprak, S. K., & Demirer, T. (2016) · Turkish Journal of Hematology · doi:10.4274/tjh.2016.0450 · Cited by 57
Akizawa, T., Nangaku, M., Yamaguchi, T., Arai, M., Koretomo, R., Maeda, K., Miyazawa, Y., & Hirakata, H. (2019) · The Nephron journals/Nephron journals · doi:10.1159/000500487 · Cited by 57
Optimizing the diagnosis and the treatment of iron overload diseases
Brissot, P. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1119043 · Cited by 55
Chun, H., Sharma, A. K., Lee, J., Chan, J., Jia, S., & Kim, B.-E. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.760876 · Cited by 55
Skeletal muscle antagonizes antiviral CD8 + T cell exhaustion
Wu, J., Weisshaar, N., Hotz‐Wagenblatt, A., Madi, A., Ma, S., Mieg, A., Hering, M., Möhr, K., Schlimbach, T., Borgers, H., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba3458 · Cited by 55
Akizawa, T., Nangaku, M., Yamaguchi, T., Koretomo, R., Maeda, K., Miyazawa, Y., & Hirakata, H. (2021) · Kidney Diseases · doi:10.1159/000517053 · Cited by 54
Ronza, P., Robledo, D., Bermúdez, R., Losada, A. P., Pardo, B. G., Sitjà‐Bobadilla, A., Quiroga, M. I., & Martı́nez, P. (2016) · International Journal for Parasitology · doi:10.1016/j.ijpara.2016.03.007 · Cited by 54
Misdistribution of iron and oxidative stress in chronic kidney disease
Nakanishi, T., Kuragano, T., Nanami, M., Nagasawa, Y., & Hasuike, Y. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.06.025 · Cited by 57
Bitopertin, a selective oral GLYT1 inhibitor, improves anemia in a mouse model of β-thalassemia
Mattè, A., Federti, E., Winter, M., Koerner, A., Harmeier, A., Mazer, N. A., Tomka, T., Paolo, M. L. D., Falco, L. D., Andolfo, I., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.130111 · Cited by 54
Akizawa, T., Nangaku, M., Yamaguchi, T., Koretomo, R., Maeda, K., Miyazawa, Y., & Hirakata, H. (2021) · Kidney International Reports · doi:10.1016/j.ekir.2021.04.037 · Cited by 54
Understanding the Recent Increase in Ferritin Levels in United States Dialysis Patients
Karaboyas, A., Zee, J., Morgenstern, H., Nolen, J. G., Hakim, R. M., Kalantar‐Zadeh, K., Zager, P. G., Pisoni, R. L., Port, F. K., & Robinson, B. M. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02600315 · Cited by 52
Ineffective Erythropoiesis in β-Thalassaemia: Key Steps and Therapeutic Options by Drugs
Longo, F., Piolatto, A., Ferrero, G. B., & Piga, A. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137229 · Cited by 53
New insights into transfusion-related iron toxicity: Implications for the oncologist
Porter, J. B., de Witte, T., Cappellini, M. D., & Gattermann, N. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.11.017 · Cited by 55
Iron dysregulation in beta-thalassemia
Leecharoenkiat, K., Lithanatudom, P., Sornjai, W., & Smith, D. R. (2016) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/j.apjtm.2016.07.035 · Cited by 52
Langer, A. L., & Ginzburg, Y. Z. (2017) · Hemodialysis International · doi:10.1111/hdi.12543 · Cited by 57
Rare anemias due to genetic iron metabolism defects
Brissot, P., Bernard, D. G., Brissot, É., Loréal, O., & Troadec, M. (2018) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2018.06.003 · Cited by 51
Gelderman, M. P., Baek, J. H., Yalamanoglu, A., Puglia, M., Vallelian, F., Burla, B., Vostal, J., Schaer, D. J., & Buehler, P. W. (2015) · Haematologica · doi:10.3324/haematol.2014.117325 · Cited by 63
Oral iron therapy: Current concepts and future prospects for improving efficacy and outcomes
Ebea, P. O., Vidyasagar, S., Connor, J. R., Frazer, D. M., Knutson, M. D., & Collins, J. F. (2024) · British Journal of Haematology · doi:10.1111/bjh.19268 · Cited by 68
Hanudel, M. R., Rappaport, M. D., Chua, K. J., Gabayan, V. R., Qiao, B., Jung, G., Salusky, I. B., Ganz, T., & Nemeth, E. (2018) · Haematologica · doi:10.3324/haematol.2017.181743 · Cited by 51
Self-citationPrentice, A. M., Bah, A., Jallow, M. W., Jallow, A. T., Sanyang, S., Sise, E. A., Ceesay, K., Danso, E., Armitage, A. E., Pasricha, S., et al. (2019) · Science Advances · doi:10.1126/sciadv.aav9020 · Cited by 51
Khandros, E., & Kwiatkowski, J. L. (2019) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2019.01.003 · Cited by 52
Hereditary xerocytosis revisited
Archer, N. M., Shmukler, B. E., Andolfo, I., Vandorpe, D. H., Gnanasambandam, R., Higgins, J. M., Rivera, A., Fleming, M. D., Sachs, F., Gottlieb, P. A., et al. (2014) · American Journal of Hematology · doi:10.1002/ajh.23799 · Cited by 50
Yun, S., & Vincelette, N. D. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.02.006 · Cited by 52
Lefèbvre, T., Dessendier, N., Houamel, D., Ialy-Radio, N., Kannengiesser, C., Manceau, H., Beaumont, C., Nicolas, G., Gouya, L., Puy, H., et al. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-1093 · Cited by 50
Iron and inflammation – the gut reaction
Verma, S., & Cherayil, B. J. (2017) · Metallomics · doi:10.1039/c6mt00282j · Cited by 51
Casu, C., Chessa, R., Liu, A., Gupta, R., Drakesmith, H., Fleming, R., Ginzburg, Y. Z., MacDonald, B., & Rivella, S. (2020) · Haematologica · doi:10.3324/haematol.2018.212589 · Cited by 50
Self-citationWang, K., Wu, J., Xu, J., Gu, S., Li, Q., Cao, P., Li, M., Zhang, Y., & Zeng, F. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00803 · Cited by 51
Guo, S., Frazer, D. M., & Anderson, G. J. (2016) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000285 · Cited by 49
Regulation of Fibroblast Growth Factor 23 by Iron, EPO, and HIF
Wheeler, J. A., & Clinkenbeard, E. L. (2019) · Current Molecular Biology Reports · doi:10.1007/s40610-019-0110-9 · Cited by 48
Haematological actions of androgens
Warren, A. M., & Grossmann, M. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101653 · Cited by 59
Low Dose Iron Treatments Induce a DNA Damage Response in Human Endothelial Cells within Minutes
Mollet, I. G., Patel, D., Govani, F. S., Giess, A. P., Paschalaki, K. E., Periyasamy, M., Lidington, E. C., Mason, J. C., Jones, M. D., Gamé, L., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147990 · Cited by 48
Xiao, X., Moschetta, G. A., Xu, Y., Fisher, A. L., Alfaro-Magallanes, V. M., Dev, S., Wang, C., & Babitt, J. L. (2022) · Blood · doi:10.1182/blood.2022017811 · Cited by 47
X-linked macrocytic dyserythropoietic anemia in females with an ALAS2 mutation
Sankaran, V. G., Ulirsch, J. C., Tchaikovskii, V., Ludwig, L. S., Wakabayashi, A., Kadirvel, S., Lindsley, R. C., Bejar, R. L., Shi, J., Lovitch, S. B., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78619 · Cited by 47
Wang, X., Zheng, X., Zhang, J., Zhao, S., Wang, Z., Wang, F., Shang, W., Barasch, J. M., & Qiu, A. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00072.2018 · Cited by 50
Shaping the bone through iron and iron-related proteins
Ledesma-Colunga, M. G., Weidner, H., Spasić, M. V., Hofbauer, L. C., Baschant, U., & Rauner, M. (2021) · Seminars in Hematology · doi:10.1053/j.seminhematol.2021.06.002 · Cited by 50
Grisouard, J., Li, S., Kubovčáková, L., Rao, T. N., Meyer, S. C., Lundberg, P., Hao-Shen, H., Romanet, V., Murakami, M., Radimerski, T., et al. (2016) · Blood · doi:10.1182/blood-2015-12-689216 · Cited by 50
HIF stabilizers in the management of renal anemia: from bench to bedside to pediatrics
Kular, D., & Macdougall, I. C. (2018) · Pediatric Nephrology · doi:10.1007/s00467-017-3849-3 · Cited by 50
Robach, P., Gammella, E., Recalcati, S., Girelli, D., Castagna, A., Roustit, M., Lundby, C., Lundby, A., Bouzat, P., Vergès, S., et al. (2020) · Haematologica · doi:10.3324/haematol.2019.233874 · Cited by 46
Autologous Blood Transfusion in Sports: Emerging Biomarkers
Salamin, O., Angelis, S. D., Tissot, J., Saugy, M., & Leuenberger, N. (2016) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2016.05.007 · Cited by 45
Enculescu, M., Metzendorf, C., Sparla, R., Hahnel, M. J., Bode, J. G., Muckenthaler, M. U., & Legewie, S. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005322 · Cited by 46
Wawer, A. A., Hodyl, N. A., Fairweather‐Tait, S. J., & Froessler, B. (2021) · Nutrients · doi:10.3390/nu13051572 · Cited by 53
Managing the Dual Nature of Iron to Preserve Health
Silvestri, L., Pettinato, M., Furiosi, V., Volpe, L. B., Nai, A., & Pagani, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043995 · Cited by 49
Nairz, M., Schroll, A., Haschka, D., Dichtl, S., Tymoszuk, P., Demetz, E., Moser, P., Haas, H., Fang, F. C., Theurl, I., et al. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00110 · Cited by 46
Iron metabolism in high-altitude residents
Muckenthaler, M. U., Mairbäurl, H., & Gassmann, M. (2020) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00019.2020 · Cited by 44
TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron Homeostasis
Ganz, T., Nemeth, E., Rivella, S., Goldberg, P., Dibble, A., McCaleb, M. L., Guo, S., Monia, B. P., & Barrett, T. D. (2023) · Advances in Therapy · doi:10.1007/s12325-022-02421-w · Cited by 44
Self-citationIron Metabolism and Inflammatory Mediators in Patients with Renal Dysfunction
Matsuoka, T., Abe, M., & Kobayashi, H. H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073745 · Cited by 53
Cazzola, M., & Malcovati, L. (2015) · Hematology · doi:10.1182/asheducation-2015.1.19 · Cited by 45
Intravenous Iron Does Not Augment the Hemoglobin Mass Response to Simulated Hypoxia
Garvican‐Lewis, L. A., Vuong, V. L., Govus, A. D., Peeling, P., JUNG, G., Nemeth, E., Hughes, D. C., Lovell, G., Eichner, D., & Gore, C. J. (2018) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001608 · Cited by 46
Self-citationIron homeostasis during anemia of inflammation: a prospective study of patients with tuberculosis
Cercamondi, C. I., Stoffel, N. U., Moretti, D., Zöller, T., Swinkels, D. W., Zeder, C., Mhimibra, F., Hella, J., Fenner, L., & Zimmermann, M. B. (2021) · Blood · doi:10.1182/blood.2020010562 · Cited by 43
Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis
Rainville, N., Jachimowicz, E., & Wojchowski, D. M. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1090975 · Cited by 45
Jiang, X., Gao, M., Chen, Y., Liu, J. L., Qi, S., Ma, J., Zhang, Z., & Xu, Y. H. (2016) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2016.02.005 · Cited by 43
Erythroferrone contributes to hepcidin repression in a mouse model of malarial anemia
Latour, C., Wlodarczyk, M. F., Jung, G., Gineste, A., Blanchard, N., Ganz, T., Roth, M., Coppin, H., & Kautz, L. (2016) · Haematologica · doi:10.3324/haematol.2016.150227 · Cited by 42
Self-citationAnemia and Red Blood Cell Transfusion
Napolitano, L. M. (2017) · Critical Care Clinics · doi:10.1016/j.ccc.2016.12.011 · Cited by 43
Landau, D., London, L., Bandach, I., & Segev, Y. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196684 · Cited by 45
Petzer, V., Tymoszuk, P., Aßhoff, M., Carvalho, J. A., Papworth, J., Deantonio, C., Bayliss, L., Wake, M., Seifert, M., Brigo, N., et al. (2020) · Blood · doi:10.1182/blood.2019004653 · Cited by 45
Self-citationCasu, C., Pettinato, M., Liu, A., Aghajan, M., Presti, V. L., Lidonnici, M. R., Munoz, K. A., O’Hara, E., Olivari, V., Modica, S. M. D., et al. (2020) · Blood · doi:10.1182/blood.2019004719 · Cited by 43
Self-citationLactate modulates iron metabolism by binding soluble adenylyl cyclase
Liu, W., Zhang, S., Li, Q., Wu, Y. X., Jia, X., Feng, W., Li, Z. A., Shi, Y., Hou, Q., Ma, J., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.06.017 · Cited by 46
Self-citationArmitage, A. E., Agbla, S. C., Betts, M., Sise, E. A., Jallow, M. W., Sambou, E., Darboe, B., Worwui, A. K., Weinstock, G. M., Antonio, M., et al. (2019) · Haematologica · doi:10.3324/haematol.2018.210146 · Cited by 41
Skrypnik, K., Bogdański, P., Sobieska, M., & Suliburska, J. (2019) · Food & Function · doi:10.1039/c9fo01006h · Cited by 42
Effect of hepcidin antagonists on anemia during inflammatory disorders
Sagar, P., Angmo, S., Sandhir, R., Rishi, V., Yadav, H., & Singhal, N. K. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107877 · Cited by 44
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors and Iron Metabolism
Ogawa, C., Tsuchiya, K., & Maeda, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24033037 · Cited by 45
Iron deficiency and supplementation in heart failure
Lakhal‐Littleton, S., & Cleland, J. G. F. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-00988-1 · Cited by 44
Rishi, G., Secondes, E. S., Wallace, D. F., & Subramaniam, V. N. (2016) · American Journal of Hematology · doi:10.1002/ajh.24417 · Cited by 41
Balance of cardiac and systemic hepcidin and its role in heart physiology and pathology
Vela, D. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.111 · Cited by 41
Garcia‐Santos, D., Hamdi, A., Saxova, Z., Fillebeen, C., Pantopoulos, K., Horváthová, M., & Ponka, P. (2017) · Blood · doi:10.1182/blood-2017-07-798728 · Cited by 40
The Postinjury Inflammatory State and the Bone Marrow Response to Anemia
Loftus, T. J., Mira, J. C., Miller, E., Kannan, K. B., Plazas, J. M., Delitto, D., Stortz, J. A., Hagen, J. E., Parvataneni, H. K., Sadasivan, K. K., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2536oc · Cited by 42
Established and Emerging Concepts to Treat Imbalances of Iron Homeostasis in Inflammatory Diseases
Petzer, V., Theurl, I., & Weiß, G. (2018) · Pharmaceuticals · doi:10.3390/ph11040135 · Cited by 41
Controversies on the Consequences of Iron Overload and Chelation in MDS
Vinchi, F., Hell, S., & Platzbecker, U. (2020) · HemaSphere · doi:10.1097/hs9.0000000000000357 · Cited by 43
Maternal, fetal and placental regulation of placental iron trafficking
O'Brien, K. O. (2021) · Placenta · doi:10.1016/j.placenta.2021.12.018 · Cited by 40
Advances in understanding iron metabolism and its crosstalk with erythropoiesis
Camaschella, C., & Pagani, A. (2018) · British Journal of Haematology · doi:10.1111/bjh.15403 · Cited by 43
Metadata
- Authors
- Kautz, L., Jung, G., Valore, E. V., Rivella, S., Nemeth, E., & Ganz, T.
- Affiliations
- University of California, Los Angeles (US)
- Weill Cornell Medicine (US)
- Corresponding author
- Ganz, Tomas
- Venue
- Nature Genetics
- Published
- 2014-06-01
- Volume
- 46
- Issue
- 7
- Pages
- 678-684
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- PMC
- PMC4104984
- OpenAlex
- W2006046265
- Cited by
- 1,127
- References
- 44
- Citations by year
- 2026: 60 · 2025: 76 · 2024: 63 · 2023: 88 · 2022: 81 · 2021: 116 · 2020: 111 · 2019: 94 · 2018: 109 · 2017: 107 · 2016: 92 · 2015: 101 · 2014: 27
- FWCI
- 72.77
- Type
- journal article
- Language
- en
- Update notices
- correction (2020-02-27)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Cancer Institute (CA-16 042, P30CA016042)
- National Institute of Allergy and Infectious Diseases (AI-28 697, P30AI028697)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK065029, R01DK090554, P30DK041301, R01DK095112)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- erythroferrone, erythropoietin, hepcidin, iron metabolism, stress erythropoiesis, erythroblasts, beta-thalassemia, thalassemia intermedia, iron overload, iron absorption, iron mobilization, iron regulatory hormone
- MeSH terms
- Epoetin Alfa, Anemia, Animals, Disease Models, Animal, Enzyme-Linked Immunosorbent Assay, Erythropoiesis, Erythropoietin, Hemoglobins, Hemorrhage, Hormones, Iron, Liver, Male, Mice, Inbred C57BL, Molecular Sequence Data, Recombinant Proteins, RNA, Messenger, Blotting, Western, beta-Thalassemia, Mice, Knockout, Iron Overload, Reverse Transcriptase Polymerase Chain Reaction, Gene Expression Profiling, Mice, Real-Time Polymerase Chain Reaction, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
